Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · IEX Real-Time Price · USD
72.56
-0.95 (-1.29%)
At close: Jul 19, 2024, 4:00 PM
72.40
-0.16 (-0.22%)
Pre-market: Jul 22, 2024, 5:26 AM EDT
Gilead Sciences Revenue
Gilead Sciences had revenue of $27.45B in the twelve months ending March 31, 2024, with 1.51% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $6.69B with 5.26% year-over-year growth. In the year 2023, Gilead Sciences had annual revenue of $27.12B.
Revenue (ttm)
$27.45B
Revenue Growth
+1.51%
P/S Ratio
3.29
Revenue / Employee
$1,525,000
Employees
18,000
Market Cap
90.40B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 27.12B | -165.00M | -0.60% |
Dec 31, 2022 | 27.28B | -24.00M | -0.09% |
Dec 31, 2021 | 27.31B | 2.62B | 10.60% |
Dec 31, 2020 | 24.69B | 2.24B | 9.98% |
Dec 31, 2019 | 22.45B | 322.00M | 1.46% |
Dec 31, 2018 | 22.13B | -3.98B | -15.24% |
Dec 31, 2017 | 26.11B | -4.28B | -14.09% |
Dec 31, 2016 | 30.39B | -2.25B | -6.89% |
Dec 31, 2015 | 32.64B | 7.75B | 31.13% |
Dec 31, 2014 | 24.89B | 13.69B | 122.19% |
Dec 31, 2013 | 11.20B | 1.50B | 15.46% |
Dec 31, 2012 | 9.70B | 1.32B | 15.70% |
Dec 31, 2011 | 8.39B | 435.97M | 5.48% |
Dec 31, 2010 | 7.95B | 938.04M | 13.38% |
Dec 31, 2009 | 7.01B | 1.68B | 31.40% |
Dec 31, 2008 | 5.34B | 1.11B | 26.14% |
Dec 31, 2007 | 4.23B | 1.20B | 39.78% |
Dec 31, 2006 | 3.03B | 997.74M | 49.19% |
Dec 31, 2005 | 2.03B | 703.78M | 53.13% |
Dec 31, 2004 | 1.32B | 456.76M | 52.63% |
Dec 31, 2003 | 867.86M | 401.07M | 85.92% |
Dec 31, 2002 | 466.79M | 233.02M | 99.68% |
Dec 31, 2001 | 233.77M | 38.21M | 19.54% |
Dec 31, 2000 | 195.56M | 26.58M | 15.73% |
Dec 31, 1999 | 168.98M | 17.86M | 11.82% |
Dec 31, 1998 | 151.12M | 18.86M | 14.26% |
Dec 31, 1997 | 132.26M | 98.84M | 295.75% |
Dec 31, 1996 | 33.42M | 28.50M | 578.99% |
Mar 31, 1995 | 4.92M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
McKesson | 308.95B |
Cigna | 206.00B |
Elevance Health | 171.96B |
HCA Healthcare | 66.72B |
Bristol-Myers Squibb Company | 45.53B |
GSK | 39.41B |
Medtronic | 32.36B |
Boston Scientific | 14.71B |
GILD News
- 4 hours ago - AHF Press Conference: Advocates Demand Gilead to Put Lives Before Profits at AIDS 2024 - Business Wire
- 4 days ago - Chief Medical Officer Merdad Parsey to Leave Gilead Early 2025 - Business Wire
- 5 days ago - Gilead to Highlight Landmark Progress in Research Across HIV Prevention, Treatment and Cure Programs at AIDS 2024 - Business Wire
- 13 days ago - Gilead Gets Analyst Upgrade on 'Outstanding' HIV Treatment Data - Investopedia
- 23 days ago - Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
- 4 weeks ago - Gilead Stock Surges on Strong Results in HIV Drug Study - Investopedia
- 4 weeks ago - Gilead's twice-yearly shot to prevent HIV succeeds in late-stage trial - CNBC
- 4 weeks ago - Gilead's HIV prevention treatment found 100% effective in late-stage trial - Market Watch